Split GFP complementation assay: a novel approach to quantitatively measure aggregation of tau in situ: effects of GSK3beta activation and caspase 3 cleavage (Q40073866)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Split GFP complementation assay: a novel approach to quantitatively measure aggregation of tau in situ: effects of GSK3beta activation and caspase 3 cleavage	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Split GFP complementation assay: a novel approach to quantitatively measure aggregation of tau in situ: effects of GSK3beta activation and caspase 3 cleavage (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

author name string

Wanjoo Chun

1

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Geoffrey S Waldo

2

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Gail V W Johnson

3

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

language of work or name

0 references

publication date

1 October 2007

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

number of pages

11

1 reference

based on heuristic

inferred from page(s)

Journal of Neurochemistry

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

103

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

2529-2539

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

Tau phosphorylation and aggregation in Alzheimer's disease pathology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

GSK3beta signalling: casting a wide net in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

Tau, tangles, and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

In vivo and in vitro protein solubility assays using split GFP.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

Protein tagging and detection with engineered self-assembling fragments of green fluorescent protein

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

Glycogen synthase kinase 3beta phosphorylates tau at both primed and unprimed sites. Differential impact on microtubule binding

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

Glycogen synthase kinase 3 beta induces caspase-cleaved tau aggregation in situ

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

The role of tau phosphorylation and cleavage in neuronal cell death

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

The role of caspase cleavage of tau in Alzheimer disease neuropathology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

Site-specific phosphorylation and caspase cleavage differentially impact tau-microtubule interactions and tau aggregation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

Structural and functional implications of tau hyperphosphorylation: information from phosphorylation-mimicking mutated tau proteins.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

Glycogen synthase kinase 3: an emerging therapeutic target

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

Memory and mental status correlates of modified Braak staging.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

The glamour and gloom of glycogen synthase kinase-3

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

Caspase-3-mediated cleavage of PHF-1 tau during apoptosis irrespective of excitotoxicity and oxidative stress: an implication to Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

Inducible expression of Tau repeat domain in cell models of tauopathy: aggregation is toxic to cells but can be reversed by inhibitor drugs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

Evaluating triggers and enhancers of tau fibrillization.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

Neurodegenerative tauopathies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

Resolution of the nuclear localization mechanism of glycogen synthase kinase-3: functional effects in apoptosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

Site-specific pseudophosphorylation modulates the rate of tau filament dissociation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

A genetic approach to identifying mitochondrial proteins

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

Phosphorylation inhibits turnover of the tau protein by the proteasome: influence of RCAN1 and oxidative stress

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

Pseudo-phosphorylation of tau at Ser202 and Thr205 affects tau filament formation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

Tau is essential to beta -amyloid-induced neurotoxicity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

Tau suppression in a neurodegenerative mouse model improves memory function

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

Hyperphosphorylation and aggregation of tau in experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

Glycogen synthase kinase-3beta phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

New frontiers in Alzheimer's disease genetics

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04941.X

21 January 2018

Identifiers

10.1111/J.1471-4159.2007.04941.X

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

release_ffobruy3czh5heo4wdgulkhwfm

1 reference

https://api.fatcat.wiki/v0/release/ffobruy3czh5heo4wdgulkhwfm

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40073866&oldid=1883662937"